APA
48
-2
AVY
37
-4
COST
54
4
ADBE
47
2
DOV
48
4
BRK.B
40
15
BAC
62
3
C
72
2
BAX
38
-3
AKAM
42
2
CA
30
3
AON
63
-2
CNX
42
-3
BIIB
51
-5
CHD
34
2
DG
33
2
AVGO
35
-3
CRM
47
2
AAPL
49
-3
AVB
35
-5
APA
48
-2
AVY
37
-4
COST
54
4
ADBE
47
2
DOV
48
4
BRK.B
40
15
BAC
62
3
C
72
2
BAX
38
-3
AKAM
42
2
CA
30
3
AON
63
-2
CNX
42
-3
BIIB
51
-5
CHD
34
2
DG
33
2
AVGO
35
-3
CRM
47
2
AAPL
49
-3
AVB
35
-5
Financhill
Back

Intellia Therapeutics Vs. Ascendis Pharma A/S - ADR Industry Stock Comparison

Sell
50

NTLA
Intellia Therapeutics

Last Price:
$10.29
Seasonality Move:
-12.18%
Sell
41

ASND
Ascendis Pharma A/S - ADR

Last Price:
$194.30
Seasonality Move:
10.37%
Sell
50
Intellia Therapeutics (NTLA) is a Sell

Is Intellia Therapeutics a Buy, Sell or Hold?

  • The current Intellia Therapeutics [NTLA] share price is $10.99. The Score for NTLA is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Ascendis Pharma A/S - ADR (ASND) is a Sell

Is Ascendis Pharma A/S - ADR a Buy, Sell or Hold?

  • The current Ascendis Pharma A/S - ADR [ASND] share price is $194.08. The Score for ASND is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NTLA Stock Price Chart

What is Intellia Therapeutics's stock price today?

  • The Intellia Therapeutics share price today is $10.99
    The current trend is moderately bullish and NTLA is experiencing selling pressure, which indicates risk of future bearish movement.

ASND Stock Price Chart

What is Ascendis Pharma A/S - ADR's stock price today?

  • The Ascendis Pharma A/S - ADR share price today is $194.08
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing slight selling pressure.

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.63 Buy
Relative Strength Index (14 RSI): 46.04 Sell
Chaikin Money Flow: -366816 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

ASND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.42 Buy
Relative Strength Index (14 RSI): 63 Buy
Chaikin Money Flow: -25667 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (167.8 - 190.72) Buy
Bollinger Bands (100): (155.29 - 180.17) Buy

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.01 Sell
20-day SMA: 11.98 Sell
50-day SMA: 10.78 Buy
200-day SMA: 10.77 Buy
8-day EMA: 10.73 Buy
20-day EMA: 8.47 Buy
50-day EMA: 4.86 Buy
200-day EMA: 1.49 Buy

ASND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 193.66 Buy
20-day SMA: 180.82 Buy
50-day SMA: 176.46 Buy
200-day SMA: 152.25 Buy
8-day EMA: 192.01 Buy
20-day EMA: 185.01 Buy
50-day EMA: 177.14 Buy
200-day EMA: 158.04 Buy

Intellia Therapeutics Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.10 per share, an increase this year of $1.17 per share, and an increase next year of $0.26 per share.

Ascendis Pharma A/S - ADR Earnings Growth & ASND Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.06 per share, an increase next quarter of $1.61 per share, an increase this year of $4.01 per share, and an increase next year of $6.29 per share.

Intellia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ascendis Pharma A/S - ADR Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):